Transplant Renal Artery Stenosis: A Case Report of Functional Recovery Six Months After Angioplasty.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
May 2021
Historique:
received: 06 03 2021
accepted: 17 03 2021
pubmed: 26 4 2021
medline: 7 7 2021
entrez: 25 4 2021
Statut: ppublish

Résumé

Transplant renal artery stenosis (TRAS) is a common vascular complication after kidney transplantation, leading to worsening or refractory hypertension, deterioration in renal function, and possible cause of graft loss. Early diagnosis and an appropriate treatment are crucial for organ preservation. Endovascular treatment, including percutaneous transluminal angioplasty and stent implantation, is considered the first-line therapy for TRAS. Here we report the case of a 69-year-old woman with end-stage renal disease for chronic kidney disease not biopsy proven, who underwent a kidney transplant from expanded criteria donors on December 2018. Postoperative course was characterized by delayed graft function. Doppler ultrasonography (US) showed an increase of peak systolic velocity at the origin of the renal artery, and parvus-tardus waveform in periferic graft arteries and an abdominal computed tomography scan confirmed a stenosis at the origin of the main renal artery (TRAS). The patient underwent a percutaneous transluminal angioplasty. It was not possible to place a stent at the particular location of the stenosis at the anastomosis. Despite the improvement of the graft's perfusion, monitored with Doppler US, the patient showed a very poor improvement in renal function and remained on hemodialysis for months. A percutaneous needle biopsy reported a normal renal parenchyma and excluded acute rejection. During this period, the patient received immunosuppressive therapy. About 6 months after the transplant, the patient had an unexpected and slow renal function recovery until she was weaned completely from hemodialysis.

Identifiants

pubmed: 33894988
pii: S0041-1345(21)00206-2
doi: 10.1016/j.transproceed.2021.03.019
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1272-1274

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Filippo Montali (F)

General and Transplant Surgery Department, University of L'Aquila, L'Aquila, Italy.

Alessandra Panarese (A)

General and Transplant Surgery Department, University of L'Aquila, L'Aquila, Italy. Electronic address: alessandra.panarese@univaq.it.

Barbara Binda (B)

General and Transplant Surgery Department, San Salvatore Hospital, L'Aquila, Italy.

Laura Lancione (L)

General and Transplant Surgery Department, San Salvatore Hospital, L'Aquila, Italy.

Francesco Pisani (F)

General and Transplant Surgery Department, University of L'Aquila, L'Aquila, Italy; General and Transplant Surgery Department, San Salvatore Hospital, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH